Risk Prediction for Breast, Endometrial, and Ovarian Cancer in White Women Aged 50 y or Older: Derivation and Validation from Population-Based Cohort Studies

Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model

(2013) Jeffrey A. Tice et al.   ANNALS OF INTERNAL MEDICINE

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

(2013) Nicolien T. van Ravesteyn et al.   ANNALS OF INTERNAL MEDICINE

Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older

(2011) Andrew N. Freedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk Factor Modification and Projections of Absolute Breast Cancer Risk

(2011) E. Petracci et al.   JNCI-Journal of the National Cancer Institute

Prevalence and Trends in Obesity Among US Adults, 1999-2008

(2010) Katherine M. Flegal   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY